• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT281218K
Device Problem Contamination (1120)
Patient Problem Bacterial Infection (1735)
Event Date 06/23/2021
Event Type  Death  
Manufacturer Narrative
According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to  infections.
 
Event Description
The following information was reported to gore: on an unknown date a patient underwent endovascular treatment with gore® excluder® aaa and iliac branch endoprostheses.Several weeks later the patient exhibited pain and infection leading to explantation of the devices.Several days later the patient expired.
 
Event Description
The following information was reported to gore: on (b)(6) 2021, a patient underwent endovascular treatment of an aorto-iliac aneurysm with gore® excluder® aaa and iliac branch endoprostheses.The procedure was uneventful and the patient was discharged within 24 hours.The patient had a history of covid19 for 7 days but he was oligosymptomatic (mild runny nose and one day of coughing).Approximately 45 days later the patient presented pain in the left iliac fossa compatible with psoitis or diverticulitis, but without fever or malaise.He presented with worsening of the condition and underwent a ct that showed retroperitoneum and intraaneurysmal abscess.He underwent exploratory laparotomy, with a large amount of pus in the retroperitonium, inside the aneurysmal sac and already in the intraperitoneal cavity.The devices were explanted and the entire aortoiliac segment was resected, followed by an axillo-bifemoral bypass.Eighteen hours later the patient expired in the icu.
 
Manufacturer Narrative
B.5.Updated: h.6.Results code 1: 213 the following device lots met all pre-release manufacturing and sterilization specifications: udi: (b)(4), sn#: (b)(6), udi: (b)(4), sn#: (b)(6), udi: (b)(4), sn#: (b)(6), udi: (b)(4), sn#: (b)(6).
 
Manufacturer Narrative
The cause of death remains unknown, however the report type has been changed to "death" as it could possibly be due to device infection.The date of death is estimated as it was stated the death was approximately 45 days post-operatively.
 
Manufacturer Narrative
Updated sections a, b and e.
 
Manufacturer Narrative
Updated: h1/h2: death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
heidi inskeep
1505 n. fourth street
phoenix, AZ 86005
9285263030
MDR Report Key12071040
MDR Text Key266955249
Report Number3007284313-2021-01480
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 03/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/08/2021
Device Catalogue NumberRLT281218K
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/23/2021
Initial Date FDA Received06/25/2021
Supplement Dates Manufacturer Received09/28/2021
09/28/2021
11/24/2021
02/21/2022
Supplement Dates FDA Received09/28/2021
10/05/2021
11/24/2021
03/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Other; Death;
Patient Age56 YR
Patient SexMale
Patient Weight80 KG
-
-